1-5 of 5
Yasutaka Chiba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies

Masatoshi Kudo, Robert Montal, Richard S. Finn, Florian Castet, Kazuomi Ueshima, Naoshi Nishida, Philipp K. Haber, Youyou Hu, Yasutaka Chiba, Myron Schwartz, Tim Meyer, Riccardo Lencioni, Josep M. Llovet
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (16): 3443–3451.
https://doi.org/10.1158/1078-0432.CCR-21-3135
Published: 15 August 2022
View article titled, Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies
Open the PDF for Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L)

Hidetoshi Hayashi, Shunichi Sugawara, Yasushi Fukuda, Daichi Fujimoto, Satoru Miura, Keiichi Ota, Yuichi Ozawa, Satoshi Hara, Junko Tanizaki, Koichi Azuma, Shota Omori, Motoko Tachihara, Kazumi Nishino, Akihiro Bessho, Yasutaka Chiba, Koji Haratani, Kazuko Sakai, Kazuto Nishio, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 893–902.
https://doi.org/10.1158/1078-0432.CCR-21-3194
Published: 01 March 2022
View article titled, A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for <em>EGFR</em>-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L)
Open the PDF for A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for <em>EGFR</em>-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L) in another window
Includes: Supplementary data
Journal Articles

HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer

Kimio Yonesaka, Junko Tanizaki, Osamu Maenishi, Koji Haratani, Hisato Kawakami, Kaoru Tanaka, Hidetoshi Hayashi, Kazuko Sakai, Yasutaka Chiba, Asuka Tsuya, Hiroki Goto, Eri Otsuka, Hiroaki Okida, Maki Kobayashi, Ryoto Yoshimoto, Masanori Funabashi, Yuuri Hashimoto, Kenji Hirotani, Takashi Kagari, Kazuto Nishio, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (2): 390–403.
https://doi.org/10.1158/1078-0432.CCR-21-3359
Published: 15 January 2022
View article titled, HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer
Open the PDF for HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation–Positive Non–Small Cell Lung Cancer

Kohsuke Isomoto, Koji Haratani, Hidetoshi Hayashi, Shigeki Shimizu, Shuta Tomida, Takashi Niwa, Toshihide Yokoyama, Yasushi Fukuda, Yasutaka Chiba, Ryoji Kato, Junko Tanizaki, Kaoru Tanaka, Masayuki Takeda, Takashi Ogura, Tadashi Ishida, Akihiko Ito, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (8): 2037–2046.
https://doi.org/10.1158/1078-0432.CCR-19-2027
Published: 15 April 2020
View article titled, Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <em>EGFR</em> Mutation–Positive Non–Small Cell Lung Cancer
Open the PDF for Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <em>EGFR</em> Mutation–Positive Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity

Kimio Yonesaka, Koji Haratani, Shiki Takamura, Hitomi Sakai, Ryoji Kato, Naoki Takegawa, Takayuki Takahama, Kaoru Tanaka, Hidetoshi Hayashi, Masayuki Takeda, Sigeki Kato, Osamu Maenishi, Kazuko Sakai, Yasutaka Chiba, Takafumi Okabe, Keita Kudo, Yoshikazu Hasegawa, Hiroyasu Kaneda, Michiko Yamato, Kenji Hirotani, Masaaki Miyazawa, Kazuto Nishio, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (11): 2653–2664.
https://doi.org/10.1158/1078-0432.CCR-17-2852
Published: 31 May 2018
View article titled, B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
Open the PDF for B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity in another window
Includes: Supplementary data